SFTH : Société Française de Thrombose et d’Hémostase (SFTH) – www.sfth.fr
The French Society of Thrombosis and Haemostasis (SFTH) was created in April 2023 from the merger between the French Study Group on Haemostasis and Thrombosis (GFHT) and CoMETH (Medical Coordination for the Study and Treatment of Constitutional Haemorrhagic Diseases). The SFTH is a cooperative group of the French Society of Hematology (SFH).
The SFTH’s mission is to advance the understanding, prevention, diagnosis and treatment of haemostasis-related conditions, in haemorrhagic and thrombotic, constitutional and acquired diseases. Our company is dedicated to the promotion of scientific discoveries, the drafting and dissemination of recommendations for good biological and clinical practices and the development of professionals, especially the youngest in the field. The SFTH maintains links with other learned societies or French organizations, such as the French Society of Hematology, the French Society of Vascular Medicine, the French Society of Anaesthesia and Resuscitation, and the Interest Group in Perioperative Haemostasis. We are also committed to the continuing education of doctors, scientists and allied health professionals.
The SFTH’s ambition is to promote the exchange of knowledge, interdisciplinary collaboration, the emergence of themes, the dissemination of scientific advances and thus to be the key player in the field of thrombosis and hemostasis. The SFTH is committed to promoting the recognition of hemostasis in all its dimensions and by all authorities. We are also committed to helping improve patient care and promote quality care, based on solid evidence and the latest research.
President
Chloe JAMES